Most of the biomarkers validated in literature, such brain natriuretic peptide, are mainly linked to the functional status of patients and the loading effect of PAH on the right ventricle, rather than the reversibility of pulmonary arteriolar lesions. This evidence concerns the gene NPPB and pulmonary arterial hypertension.